Schedule 13G ownership disclosure
ARS Pharmaceuticals Inc
Security class unavailable · CUSIP: 82835W108
Event date: 2022-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,910,029
- Percent of class
- 2.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-021746
- Form type
- SC 13G
- Filer
- ARS Pharmaceuticals, Inc.
- CIK
- CIK 1671858
- Filed
- Feb 14, 2023
- Reporting period
- Dec 31, 2022
- Description
- Schedule 13G beneficial ownership